JP2016537010A5 - - Google Patents

Download PDF

Info

Publication number
JP2016537010A5
JP2016537010A5 JP2016540920A JP2016540920A JP2016537010A5 JP 2016537010 A5 JP2016537010 A5 JP 2016537010A5 JP 2016540920 A JP2016540920 A JP 2016540920A JP 2016540920 A JP2016540920 A JP 2016540920A JP 2016537010 A5 JP2016537010 A5 JP 2016537010A5
Authority
JP
Japan
Prior art keywords
subject
luminal
breast cancer
biological sample
subtype
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016540920A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016537010A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/054760 external-priority patent/WO2015035377A1/en
Publication of JP2016537010A publication Critical patent/JP2016537010A/ja
Publication of JP2016537010A5 publication Critical patent/JP2016537010A5/ja
Pending legal-status Critical Current

Links

JP2016540920A 2013-09-09 2014-09-09 予後を予測するための方法及びキット、並びに、放射線照射療法を用いた乳癌の治療方法及びキット Pending JP2016537010A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361875373P 2013-09-09 2013-09-09
US61/875,373 2013-09-09
US201461990948P 2014-05-09 2014-05-09
US61/990,948 2014-05-09
PCT/US2014/054760 WO2015035377A1 (en) 2013-09-09 2014-09-09 Methods and kits for predicting outcome and methods and kits for treating breast cancer with radiation therapy

Publications (2)

Publication Number Publication Date
JP2016537010A JP2016537010A (ja) 2016-12-01
JP2016537010A5 true JP2016537010A5 (cg-RX-API-DMAC7.html) 2017-09-14

Family

ID=51688397

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016540920A Pending JP2016537010A (ja) 2013-09-09 2014-09-09 予後を予測するための方法及びキット、並びに、放射線照射療法を用いた乳癌の治療方法及びキット

Country Status (7)

Country Link
US (1) US20150072021A1 (cg-RX-API-DMAC7.html)
EP (1) EP3044332A1 (cg-RX-API-DMAC7.html)
JP (1) JP2016537010A (cg-RX-API-DMAC7.html)
AU (1) AU2014317843A1 (cg-RX-API-DMAC7.html)
CA (1) CA2923166A1 (cg-RX-API-DMAC7.html)
IL (1) IL244421A0 (cg-RX-API-DMAC7.html)
WO (1) WO2015035377A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030198972A1 (en) 2001-12-21 2003-10-23 Erlander Mark G. Grading of breast cancer
HRP20140140T1 (en) 2008-05-30 2014-05-23 The University Of North Carolina At Chapel Hill Gene expression profiles to predict breast cancer outcomes
ES2756399T3 (es) 2014-11-24 2020-04-27 Nanostring Technologies Inc Métodos y aparatos para la purificación y formación de imágenes de genes
AU2015359479A1 (en) * 2014-12-09 2017-06-15 King's College London Breast cancer treatment with taxane therapy
MX2018005867A (es) 2015-11-13 2018-09-21 Biotheranostics Inc Integracion de las caracteristicas tumorales con el indice de cancer de mama.
JOP20170053B1 (ar) 2016-03-02 2021-08-17 Eisai Randd Man Co Ltd مترافقات جسم مضاد وعقار أساسها إيريبولين وطرق استخدامها
CN107574243B (zh) * 2016-06-30 2021-06-29 博奥生物集团有限公司 分子标志物、内参基因及其应用、检测试剂盒以及检测模型的构建方法
CN108456730B (zh) * 2018-02-27 2021-01-05 海门善准生物科技有限公司 一种复发风险基因群作为标志物在制备评估乳腺癌分子分型内远处复发风险的产品中的应用
EP3946383A4 (en) * 2019-04-04 2023-05-03 University of Utah Research Foundation MULTIGENIC ANALYSIS TO PREDICT THE RISK OF CANCER RELEASE
KR102414754B1 (ko) * 2019-10-10 2022-06-30 주식회사 종근당 직장암 항암화학방사선 치료 반응 예측용 바이오마커
TW202129008A (zh) * 2019-11-05 2021-08-01 香港商行動基因(智財)有限公司 檢測異檸檬酸脫氫酶突變的套組及方法
EP3945136A1 (en) * 2020-07-28 2022-02-02 Hospital Clínic de Barcelona In vitro method for the prognosis of patients suffering from her2-positive breast cancer
CN113278700B (zh) * 2021-06-04 2022-08-09 浙江省肿瘤医院 一种用于乳腺癌分型及预后预测的引物组及试剂盒
KR20240081508A (ko) 2022-11-17 2024-06-10 인제대학교 산학협력단 Dna 메틸화 변화를 통한 방사선치료 반응성 예측용 바이오마커 조성물 및 이의 용도
CN116622885B (zh) * 2023-05-23 2025-01-10 福建省农业科学院果树研究所 一种用于不同桃花色鉴定的分子标记方法及其应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4843155A (en) 1987-11-19 1989-06-27 Piotr Chomczynski Product and process for isolating RNA
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
EP0773227A1 (en) 1991-09-18 1997-05-14 Affymax Technologies N.V. Diverse collections of oligomers in use to prepare drugs, diagnostic reagents, pesticides or herbicides
ATE293011T1 (de) 1991-11-22 2005-04-15 Affymetrix Inc A Delaware Corp Kombinatorische strategien für die polymersynthese
US5384261A (en) 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
US5856174A (en) 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
US5854033A (en) 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
EP0880598A4 (en) 1996-01-23 2005-02-23 Affymetrix Inc RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM
US6033860A (en) 1997-10-31 2000-03-07 Affymetrix, Inc. Expression profiles in adult and fetal organs
US6020135A (en) 1998-03-27 2000-02-01 Affymetrix, Inc. P53-regulated genes
US20080032293A1 (en) 2004-07-15 2008-02-07 The University Of North Carolina At Chapel Hill Housekeeping Genes And Methods For Identifying Same
EP1954708A4 (en) 2005-11-23 2009-05-13 Univ Utah Res Found Methods and compositions involving intrinsic genes
US8986926B2 (en) 2005-12-23 2015-03-24 Nanostring Technologies, Inc. Compositions comprising oriented, immobilized macromolecules and methods for their preparation
EP1963531B1 (en) 2005-12-23 2011-09-21 Nanostring Technologies, Inc. Nanoreporters and methods of manufacturing and use thereof
WO2007084992A2 (en) * 2006-01-19 2007-07-26 The University Of Chicago Prognosis and therapy predictive markers and methods of use
JP5555157B2 (ja) 2007-04-10 2014-07-23 ナノストリング テクノロジーズ, インコーポレイテッド ナノレポーターにおける使用のための標的特異的配列を同定するための方法およびコンピュータシステム
CA2698569A1 (en) * 2007-09-06 2009-09-03 Mark G. Erlander Tumor grading and cancer prognosis
EP2195005B1 (en) * 2007-09-14 2015-05-27 University of South Florida Gene signature for the prediction of radiation therapy response
HRP20140140T1 (en) 2008-05-30 2014-05-23 The University Of North Carolina At Chapel Hill Gene expression profiles to predict breast cancer outcomes
JP5836803B2 (ja) 2008-08-14 2015-12-24 ナノストリング テクノロジーズ, インコーポレイテッド 安定したナノレポーター
CA2857505A1 (en) * 2011-11-30 2013-06-06 The University Of North Carolina At Chapel Hill Methods of treating breast cancer with taxane therapy
AU2013266419B2 (en) * 2012-05-22 2018-09-27 British Columbia Cancer Agency Branch NANO46 genes and methods to predict breast cancer outcome

Similar Documents

Publication Publication Date Title
JP2016537010A5 (cg-RX-API-DMAC7.html)
Das et al. Biomarkers in cancer detection, diagnosis, and prognosis
JP2010538609A5 (cg-RX-API-DMAC7.html)
ES2730384T3 (es) Puntuación de la infiltración linfocitaria de los tumores
ES2550192T3 (es) Biomarcadores para el cáncer de pulmón
Arnedos et al. Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trial
JP2016174600A5 (cg-RX-API-DMAC7.html)
Stav et al. Usefulness of CDK5RAP3, CCNB2, and RAGE genes for the diagnosis of lung adenocarcinoma
JP2014514278A5 (cg-RX-API-DMAC7.html)
JP2017503481A5 (cg-RX-API-DMAC7.html)
CN106148529B (zh) 与胃癌相关的LncRNA标记物及其专用检测引物、检测方法、试剂盒与应用
Gerashchenko et al. Intratumoral morphological heterogeneity of breast cancer as an indicator of the metastatic potential and tumor chemosensitivity
JP2018527886A5 (cg-RX-API-DMAC7.html)
JP2015210268A5 (cg-RX-API-DMAC7.html)
WO2017210691A1 (en) Methods for predicting risk of recurrence and/or metastasis in soft tissue sarcoma
ES2877689T3 (es) miARN circulantes como marcador de detección temprana y marcador pronóstico
JP2018512160A5 (cg-RX-API-DMAC7.html)
US20120244531A1 (en) Method for providing information for diagnosing cancer using quantitative real-time pcr and kit for diagnosing cancer for the same
JP2017516501A5 (cg-RX-API-DMAC7.html)
JP2022009848A (ja) 扁平上皮がんに対する化学放射線療法の有効性を評価するための方法
JP2013532489A (ja) 遺伝子発現プロファイリングに基づくがん治療への応答の予測ならびにモニタリング
Chuthapisith et al. Breast cancer subtypes identified by the ER, PR and HER-2 status in Thai women
JP2011527575A5 (cg-RX-API-DMAC7.html)
Kim et al. DICER1 exons 25 and 26 mutations are rare in common human tumours besides Sertoli-Leydig cell tumour.
Zhou et al. Increased expression of long non-coding RNA SBDSP1 correlates with poor survival in colorectal cancer